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what administration intervals are used in the development and validation of 
PROs, as a first step towards ascertaining the most appropriate interval between 
administrations for test-retest and equivalence studies for different measures. 
METHODS: A literature review was conducted using the following search terms: 
test retest reliability, equivalence testing, washout period, and interval on 
Psychinfo since January 2003. 554 abstracts were identified. Thirty-two 
additional abstracts from an equivalence study review paper were included 
resulting in a total of 586 abstracts. All abstracts were reviewed and where 
available the administration interval was extracted and collated. RESULTS: One 
percent of the test retest studies had an interval of one hour or less, 18% had an 
interval of 1 day to 1 week, 25% had an interval of 1weeks to 2 weeks, 21% had an 
interval of 2 weeks to 1 month, 9% had an interval of 1 to 2 month, 13 % had an 
interval of 2 months or over, 13% reported a varied interval. In contrast, 50% of 
the equivalence studies had an administration interval of 1 hour or less, 9% had 
an interval of 1 hour to 1 day, 28% had an interval of 1 day to 1 week, 3% an 
interval of 1 to 2 weeks 10% reported a varied interval within the same study. 
CONCLUSIONS: There is a wide variety of administration intervals used in test-
retest and equivalence studies seen within the literature. Considerations around 
the appropriate administration interval to use should be based on, amongst 
other things, an assessment of the stability of the condition involved and the 
complexity of the PRO.  
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OBJECTIVES: Current questionnaires assessing the impact of nocturia (waking up 
at night one or more times to void), e.g. N-QoL, ICIQ-N or IPSS, do not fulfill the new 
FDA PRO guidelines. We report on the development of a new nocturia impact 
measure. METHODS: The following recommended steps were undertaken: 1) 
Literature review identifying an exhaustive pool of concepts, hereafter 
development of draft diary; 2) Cognitive debriefing test (n=23) confirming 
relevance and importance of items and understandability of phrasing. 
Preliminary Rasch analysis. Modified diary developed and 3) Reliability, validity, 
sensitivity and dimensionality tested in randomized, placebo-controlled trial 
(n=56). RESULTS: Step 1 generated 4 domains including 14 items with 5 response 
options (‘a great deal’ to ‘not at all’). Step 2: Content validity supported 11 items 
and suggested 1 new. Revision into a 12-item diary with 2 domain scores. Step 3: 
Dimensionality: Factor and Rasch analyses clearly indicated uni-dimensionality. 
Construct Validity: Known group validity (<3/≥3 voids): Total score D-13.6 points 
at baseline, p=0.03. Fit to Rasch model at baseline 2 of 3 p= >0.05. Reliability: 
Stability over time=0.91. Internal consistency: Cronbachs alpha=0.9. Sensitivity: 
Cohen’s D=0.73. High variance in response options, slight floor effect. Person 
correlation with number of voids=0.31, p=0.02. Final NI diary: Nocturia Impact 
total score calculated from 11 core items. Global impact question (Q12) analyzed 
separately. CONCLUSIONS: All validity and reliability tests of the Nocturia 
Impact Diary® were highly supportive. The sensitivity was acceptable, especially 
the calculation of Cohen’s D based on pooled analysis. The Nocturia Impact 
Diary® is the first nocturia impact assessment tool developed in close dialog with 
FDA and in accordance with the new PRO guidelines. Consequently, it represents 
a valid new tool within nocturia and should be used in conjunction with voiding 
diaries in cross sectional assessments of patient burden or in assessments of 
changes due to treatment of nocturia.  
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OBJECTIVES: To utilize a specific approach in questionnaire design (general to 
specific items) to identify evidences of existing (but initially denied) spasticity-
related pain (SRP) in children with Cerebral Palsy (CP). METHODS: Children and 
adolescents with CP and SRP and their parent/caregivers participated in 
qualitative interviews to evaluate the Questionnaire on Pain Caused by Spasticity 
(QPS), a newly developed Patient Reported and Observer Reported Outcome 
measure that assesses SRP. Interviews were audio recorded and transcribed. 
Child/adolescent questionnaires were compared with the one from their 
corresponding parent/caregiver’s to identify differences in answers provided for 
presence of SRP. Questions first asked about SRP in general, and then in specific 
activity situations (at rest, during usual daily activities, during active 
mobilization, and during physically difficult activities). RESULTS: Eight children 
and adolescents (7-16 years) who participated with their parent/caregivers were 
used for this evaluation. Clinicians confirmed at enrollment that all subjects had 
SRP weekly to daily. Four of the 8 participants reported having no pain on the 
initial general SRP item, yet proceeded to describe their pain in subsequent items 
that asked about severity of pain in specific activity situations. Parent/caregiver 
responses indicated observation of signs of their child’s pain on both the general 
item and the various activity situations. CONCLUSIONS: Because earlier 
qualitative interview data documented instances where children and 
adolescents reported intentionally hiding their pain from their parent/caregivers, 
there is a concern that self-reported pain data may not be trustworthy in this 
population. However, these findings suggest that combining a self-reported and 
an observer-reported assessment produces complimentary results that facilitate 
more accurate measurement of SRP. Results also suggest that in the assessment 
of chronic conditions, structuring child/adolescent questionnaires to make 
multiple (general to descriptive) inquiries of the same concept might facilitate 
discovery of symptoms being initially denied.  
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OBJECTIVES: To review both idiomatic items and items with literal phrasing 
within Patient Reported Outcomes instruments in order to assess subject 
comprehension and preference. Idiomatic items commonly appear in 
psychological questionnaires and clinical outcomes assessments, and frequently 
require translation for use in multinational clinical trials. Though it is theorized 
that idiomatic items will be more comprehensible to lay audiences, previous 
research has shown that they require more rounds of revision during linguistic 
validation in order to achieve conceptual equivalence. METHODS: A patient 
questionnaire containing six idiomatic items underwent linguistic validation in 
six languages. For each item, a literal equivalent was developed and translated. 
During cognitive debriefing, a sample of 147 subjects was presented with both 
idiomatic and literal versions of the six items. Subjects were asked to comment 
on comprehensibility and preference. A control group of 7 subjects was asked for 
feedback on these items in U.S. English. RESULTS: Cognitive debriefing data 
showed preference for the literal item 59% of the time, and for the idiomatic item 
37% of the time. Subjects made no decision 4% of the time. No correlation was 
found between years of education and preference. Only 2 instances of 
comprehension issues occurred, both with the idiomatic items. Literal items 
yielded no comprehension issues. In some languages, an idiomatic equivalent 
was unavailable; these items were omitted from the analysis. Subjects in the 
English-U.S. control group preferred the literal item 74% of the time. 
CONCLUSIONS: In previous research, idiomatic items were shown to require one 
to two more rounds of revision than literal items during translation. Given that 
literal items were understood by all sample members with less than 12 years of 
education, and were preferred by a majority, avoidance of idiomatic items in 
patient questionnaires is recommended.  
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OBJECTIVES: The Disease Burden Scale (DBS), a 4-item instrument derived from 
the Diabetes Burden Scale (Kaplan 2010), measures the impact of specific health 
conditions on a patient’s overall health, social activities, lifestyle and finances. 
We sought to build on prior validation of the parent instrument by evaluating 
the validity and reproducibility of the DBS and testing equivalence between 
paper and electronic administration modes. METHODS: Adult patients with 
depression, type 2 diabetes, or rheumatoid arthritis were recruited through web-
based advertisements in 8 U.S. cities and completed the DBS on both paper and 
computerized format in a randomized crossover design. A one-week retest was 
also completed. Reproducibility and mode equivalence were assessed using the 
intraclass correlation coefficient (ICC). Cronbach’s alpha was calculated to assess 
internal consistency. To assess convergent validity, the correlation of the DBS to 
the WHO Quality of Life Scale (WHOQOL-BREF) was calculated. ANOVA was used 
to compare mean DBS scores among known groups defined by the MOS-36 MCS 
and PCS subscales. RESULTS: Of the 230 participants that completed baseline 
assessment, 228 (99.1%) completed the one-week retest. The mean age of 
participants was 44.3 years, 51.3% were female, and 58.3% were Caucasian. A 
small amount (n=9; 3.9%) reported their health as Poor. The mean paper DBS 
score was 44.8 (±26.6), and the ICC between paper and computerized 
administration was 0.876. The ICC for the one-week retest of the paper format 
was 0.944, and the DBS was found to be internally consistent (Cronbach’s 
alpha=0.899). Significant correlations were found with the WHOQOL-BREF 
(r=0.460 to 0.646; p<0.01) and the instrument discriminated between 
hypothesized MOS-36 score groups (MCS, p<0.01; PCS, p<0.01). CONCLUSIONS: 
The DBS was observed to be reproducible and internally consistent, 
demonstrated appropriate convergent validity, and significantly discriminated 
between levels of overall health status. Equivalence between paper and web-
based administration was demonstrated.  
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OBJECTIVES: Axial spondyloarthritis (axSpA) includes both ankylosing 
spondylitis (AS) and non-radiographic axSpA (nr-axSpA, axSpA with no 
definitive sacroiliitis on X-ray). Several patient-reported outcome (PRO) 
instruments have been validated in AS. This study evaluated the content 
validity, and assessed the psychometric measurement properties, of such PROs 
in the broad axSpA population. METHODS: PROs assessed: Total and Nocturnal 
Spinal Pain Numerical Rating Scales, PtGA, BASDAI (including fatigue and 
